Supercharged immune cells take on viruses in transplant patients
NCT ID NCT01325636
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tested whether giving special immune cells (T cells) that target CMV or adenovirus could help control these infections in people who had a stem cell transplant. Sixteen children and adults with persistent or drug-resistant infections received the cells. The main goal was to see if the treatment could lower virus levels in the blood within three weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotherapy department, Hôpital Necker - Enfants Malades
Paris, 75743, France
Conditions
Explore the condition pages connected to this study.